UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053096
Receipt number R000060591
Scientific Title Development of an artificial intelligence system to support early diagnosis of pancreatic cancer using multiparametric MRI
Date of disclosure of the study information 2023/12/14
Last modified on 2023/12/13 21:36:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of an artificial intelligence system to support early diagnosis of pancreatic cancer using multiparametric MRI

Acronym

Development of an artificial intelligence system to support early diagnosis of pancreatic cancer using multiparametric MRI

Scientific Title

Development of an artificial intelligence system to support early diagnosis of pancreatic cancer using multiparametric MRI

Scientific Title:Acronym

Development of an artificial intelligence system to support early diagnosis of pancreatic cancer using multiparametric MRI

Region

Japan


Condition

Condition

Pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Development of an artificial intelligence system to support early diagnosis of pancreatic cancer using multiparametric MRI

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sensitivity, specificity

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

None

Key exclusion criteria

None

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name NOBUHIKO
Middle name
Last name FUKUBA

Organization

Shimane University

Division name

Internal medicine II

Zip code

6938501

Address

89-1,Enya-cho, Izumo, Shimane,Japan

TEL

0853-23-2111

Email

nfukuba@med.shimane-u.ac.jp


Public contact

Name of contact person

1st name NOBUHIKO
Middle name
Last name FUKUBA

Organization

Shimane University

Division name

Internal medicine II

Zip code

6938501

Address

89-1,Enya-cho, Izumo, Shimane,Japan

TEL

0853232111

Homepage URL


Email

nfukuba@med.shimane-u.ac.jp


Sponsor or person

Institute

Shimane University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Research Ethics Committee,Shimane University Faculty of Medicine

Address

89-1,Enya-cho, Izumo, Shimane,Japan

Tel

0853-20-2515

Email

kenkyu@med.shimane-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 12 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 12 Month 13 Day

Date of IRB


Anticipated trial start date

2023 Year 12 Month 13 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We will develop an AI diagnostic support model using deep learning using MRI image data from Shimane University and affiliated hospitals, and evaluate sensitivity, specificity, positive predictive value, and negative predictive value using a test set.


Management information

Registered date

2023 Year 12 Month 13 Day

Last modified on

2023 Year 12 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060591


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name